Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/31/2015 09/01/2015 09/02/2015 09/03/2015 09/04/2015 Date
129.24(c) 124.63(c) 129.26(c) 126.45(c) 126.51(c) Last
1 156 542 1 305 331 1 079 639 854 667 696 043 Volume
-2.96% -3.57% +3.71% -2.17% +0.05% Change
More quotes
Financials ($)
Sales 2015 898 M
EBIT 2015 -326 M
Net income 2015 -349 M
Debt 2015 73,8 M
Yield 2015 -
Sales 2016 1 118 M
EBIT 2016 -198 M
Net income 2016 -280 M
Debt 2016 208 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 22,8x
EV / Sales 2016 18,4x
Capitalization 20 370 M
More Financials
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
10/22Earnings Release
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
09/02 BIOMARIN PHARMACEUTICAL : Study Data from BioMarin Pharmaceutical Update Underst..
09/02 BIOMARIN PHARMACEUTICAL : Launches kNOWyourDuchenne, Comprehensive Program for P..
09/02 BioMarin to Attend Upcoming Investor Conferences in September
09/01 BioMarin Launches kNOWyourDuchenne, Comprehensive Program for Patients With D..
08/31 BIOMARIN PHARMACEUTICAL : Announces Two Oral and 19 Poster Presentations at the ..
08/31 MEDIVATION : Acquires Worldwide Rights to Talazoparib (BMN 673) from BioMarin
08/27 MEDIVATION : Purchases Worldwide Rights to Talazoparib (BMN 673) from BioMarin
08/26 BIOMARIN PHARMACEUTICAL : gets Planning Commission approval on four-story buildi..
More news
Sector news : Generic Pharmaceuticals
06:03a ABBVIE : Drug ads include a lot of warnings -- probably too many, FDA says
06:03a HOSPIRA : A $90 million payday for Hospira CEO after sale to Pfizer
06:03a SANOFI : Nothing like a good cry: Contra Costa County's own 'town crier'
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
09/02 BioMarin Still Solid For 2015
09/02 Medivation Destined To Become Biotech Behemoth As Low Risk Pipeline Expands
08/25 Biomarin Goes For Pragmatism As The Markets Dip
08/25 PREMARKET BIOTECH DIGEST : SA Author On Valeant, Stocks Tumble, Novartis Promact..
08/24 Medivation to acquire all worldwide rights to talazoparib from BioMarin


Comments 
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends BIOMARIN PHARMACE...
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions